Home
Conditions
Endocrine Gland Neoplasms

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,089 public trials 1,370 recruiting studies

Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors

NCT01572467

Conditions: Adnexal Diseases, Childhood Germ Cell Tumor, Endocrine Gland Neoplasms, +25 more
Locations: Not specified

View Trial Details

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer

NCT00026403

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

MBCCOP - Howard University Cancer Center Washington D.C., District of Columbia, United States

CCOP - Illinois Oncology Research Association Peoria, Illinois, United States

Methodist Medical Center of Illinois Peoria, Illinois, United States

View all 26 locations

View Trial Details

Completed

Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach

NCT00003157

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

CCOP - Illinois Oncology Research Association Peoria, Illinois, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States

View all 18 locations

View Trial Details

Completed

Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00091377

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States

Royal Women's Hospital Carlton, Victoria, Australia

View Trial Details

Completed

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

NCT00033605

Conditions: Adnexal Diseases, Cervical Cancer, Colonic Diseases, +53 more
Locations: Not specified

View Trial Details

Completed

Tumor Gene Expression in Women With Ovarian Cancer

NCT00817479

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects

NCT01450046

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

NCT00003704

Conditions: Adnexal Diseases, Anus Diseases, Anus Neoplasms, +56 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States

CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States

View all 18 locations

View Trial Details

Completed

Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

NCT00006467

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States

CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States

View all 16 locations

View Trial Details

Completed

Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer

NCT00696696

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations: Desert Regional Medical Center Palm Springs, California, United States

Bellevue Hospital New York, United States

New York University Cancer Center New York, United States

View Trial Details

Endocrine Gland Neoplasms

Endocrine Gland Neoplasms trial results

Related conditions